Skip to main content
. 2022 Nov 2;33(1):179–187. doi: 10.1007/s11695-022-06350-z

Table 3.

Weight loss outcomes in the three groups.*

Patients with T2D Patients without T2D p value
Remitters Non-remitters
δ BMI (kg/m2)
1st year 13.2 [8.1]§ 11.5 [5.1] 15.4 [6.2] 0.0002
2nd year 15.4 [7.8]§ 11.8 [6.3]# 16.4 [7.3] 0.0006
3rd year 15.5 [7.7] 9.7 [5.0]# 16.2 [8.1] 0.004
4th year 15.7 [7.9] 9.0 [7.3]# 16.7 [8.4] 0.03
5th year 15.0 [7.2] 8.0 [7.1]# 16.3 [8.7] 0.02
Percentage of WL (%)
1st year 29.8 [11.4]§ 24.0 [9.0]# 34.1 [10.5]  < 0.0001
2nd year 32.9 [12.4]§ 24.5 [16.1]# 36.9 [11.6]  < 0.0001
3rd year 32.9 [15.4] 23.3 [12.0]# 36.4 [11.9] 0.0006
4th year 32.9 [14.6] 23.4 [0.17]# 35.6 [13.2] 0.005
5th year 30.0 [14.6] 19.2 [15.3]# 34.5 [12.5] 0.004
Percentage of EWL (%)
1st year 68.1 [27.9]§ 53.0 [19.0]# 75.3 [26.1] 0.0003
2nd year 72.3 [24.0]§ 58.3 [32.9]# 81.5 [29.2] 0.0002
3rd year 73.7 [24.3] 53.8 [31.7]# 79.6 [27.6]  < 0.0001
4th year 70.5 [22.7] 53.1 [47.1]# 77.6 [28.2] 0.004
5th year 67.5 [14.7] 51.8 [42.8]# 76.3 [31.9] 0.003

*Entries are median [interquartile range]. p value: comparison between patients without T2D and patients with T2D; #indicates p < 0.05 in the comparison between remitters and non-remitters; §indicates p < 0.05 in the comparison between remitters and patients without T2D. WL, weight loss; EWL, excess body weight loss